User contributions
Jump to navigation
Jump to search
- 23:50, 18 March 2019 diff hist +535 Squamous odontogenic tumour →General
- 23:47, 18 March 2019 diff hist +41 N SOT redirect current
- 23:46, 18 March 2019 diff hist +70 Odontogenic tumours and cysts →Odontogenic myxoma
- 23:46, 18 March 2019 diff hist 0 Squamous odontogenic tumour →Microscopic
- 23:45, 18 March 2019 diff hist 0 Squamous odontogenic tumour
- 23:45, 18 March 2019 diff hist +906 N Squamous odontogenic tumour create
- 23:31, 18 March 2019 diff hist +346 Parathyroid glands →Genetics
- 23:27, 18 March 2019 diff hist +706 Parathyroid glands →Overview in a table
- 17:29, 18 March 2019 diff hist −9 OKC redirect current
- 17:29, 18 March 2019 diff hist −9 KOT redirect current
- 17:29, 18 March 2019 diff hist −5,455 Keratocystic odontogenic tumour redirect current
- 17:28, 18 March 2019 diff hist +7 Odontogenic keratocyst
- 17:27, 18 March 2019 diff hist +6,090 Odontogenic keratocyst update
- 13:11, 18 March 2019 diff hist +24 Enzalutamide →See also current
- 13:10, 18 March 2019 diff hist +24 Abiraterone →See also current
- 13:09, 18 March 2019 diff hist +18 Androgen receptor →See also current
- 13:09, 18 March 2019 diff hist +19 Androgen receptor →See also
- 13:08, 18 March 2019 diff hist 0 Enzalutamide
- 13:08, 18 March 2019 diff hist +4 Enzalutamide
- 13:08, 18 March 2019 diff hist +149 Androgen receptor antibodies
- 04:36, 18 March 2019 diff hist −9 Squamous cell carcinoma of the head and neck
- 04:35, 18 March 2019 diff hist +87 Squamous cell carcinoma of the head and neck →Basaloid squamous cell carcinoma
- 04:34, 18 March 2019 diff hist +4 Sinonasal undifferentiated carcinoma
- 04:34, 18 March 2019 diff hist +4 Sinonasal undifferentiated carcinoma →Microscopic
- 04:33, 18 March 2019 diff hist +283 SMARCB1-deficient sinonasal carcinoma
- 04:26, 18 March 2019 diff hist +4 SMARCB1-deficient sinonasal carcinoma →Microscopic
- 04:25, 18 March 2019 diff hist +118 SMARCB1-deficient sinonasal carcinoma →Microscopic
- 00:56, 18 March 2019 diff hist +209 SMARCB1-deficient sinonasal carcinoma
- 00:53, 18 March 2019 diff hist +892 N SMARCB1-deficient sinonasal carcinoma Created page with "'''SMARCB1-deficient sinonasal carcinoma''' is a rare malignant tumour of the head and neck with loss of SMARCB1 staining.<ref>{{Cite journal..."
- 00:47, 18 March 2019 diff hist +37 NUT carcinoma →IHC
- 00:44, 18 March 2019 diff hist +4 SMARCA4-deficient non-small cell carcinoma of the lung →General
- 00:42, 18 March 2019 diff hist +16 SMARCA4-deficient non-small cell carcinoma of the lung →General
- 00:42, 18 March 2019 diff hist +81 SMARCA4-deficient non-small cell carcinoma of the lung →General
- 00:33, 18 March 2019 diff hist +4 SMARCA4-deficient non-small cell carcinoma of the lung →IHC
- 00:32, 18 March 2019 diff hist +4 SMARCA4-deficient non-small cell carcinoma of the lung →IHC
- 00:32, 18 March 2019 diff hist +534 SMARCA4-deficient non-small cell carcinoma of the lung →IHC
- 00:20, 18 March 2019 diff hist +3 Epithelial-myoepithelial carcinoma →General
- 00:16, 18 March 2019 diff hist +496 Epithelial-myoepithelial carcinoma →General: weak
- 00:13, 18 March 2019 diff hist +41 Epithelial-myoepithelial carcinoma of lung →See also current
- 00:12, 18 March 2019 diff hist 0 Epithelial-myoepithelial carcinoma of lung
- 00:12, 18 March 2019 diff hist +602 N Epithelial-myoepithelial carcinoma of lung Created page with "'''Epithelial-myoepithelial carcinoma of lung''' is a salviary gland-type tumour of the lung.<ref>{{Cite journal | last1 = Nakashima | first1 = Y. | last2..."
- 00:01, 18 March 2019 diff hist +44 Inflammatory myofibroblastic tumour →General
- 23:58, 17 March 2019 diff hist +4 ALK inhibitors
- 23:58, 17 March 2019 diff hist +29 Crizotinib
- 23:57, 17 March 2019 diff hist +52 ALK inhibitors
- 23:57, 17 March 2019 diff hist +4 Lung carcinoma with ALK rearrangement →General current
- 23:55, 17 March 2019 diff hist +557 ALK inhibitors
- 23:54, 17 March 2019 diff hist +28 N ALK inhibitor Redirected page to ALK inhibitors current
- 23:53, 17 March 2019 diff hist +807 N ALK inhibitors Created page with "'''ALK inhibitors''' are a group of drugs that act on tumours with ALK rearrangements. *Alectinib.<ref name=pmid30790150>{{Cite journal | last1 = Honda | first1 = K. | last2..."
- 23:51, 17 March 2019 diff hist +1,130 Inflammatory myofibroblastic tumour →General